Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Axel Grothey, MD, Talks About the Upcoming ESMO World Congress on GI Cancer
Videos
Axel Grothey, MD, Talks About the Upcoming ESMO World Congress on GI Cancer
06/22/2020
Dr Grothey tells us what we can look forward to at the 22nd ESMO World Congress on Gastrointestinal Cancer, which is taking place virtually this year.
Dr Grothey tells us what we can look forward to at the 22nd ESMO World Congress on Gastrointestinal Cancer, which is taking place virtually this year.
Dr Grothey tells us what we can...
06/22/2020
Oncology
Solange Peters, MD, PhD, on What to Expect at the Virtual ESMO World Congress on GI Cancer
Videos
Solange Peters, MD, PhD, on What to Expect at the Virtual ESMO World Congress on GI Cancer
06/21/2020
The President of ESMO discusses what attendees of the annual ESMO World Congress on GI Cancer can expect from the virtual 2020 event.
The President of ESMO discusses what attendees of the annual ESMO World Congress on GI Cancer can expect from the virtual 2020 event.
The President of ESMO discusses...
06/21/2020
Oncology
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
Videos
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
06/03/2020
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses...
06/03/2020
Oncology
Overcoming COVID-19 Hurdles in Routine Clinical Practice
Videos
Overcoming COVID-19 Hurdles in Routine Clinical Practice
04/16/2020
Axel Grothey, MD, talks about how healthcare providers are rising to face the challenges presented by the COVID-19 pandemic in routine clinical practice.
Axel Grothey, MD, talks about how healthcare providers are rising to face the challenges presented by the COVID-19 pandemic in routine clinical practice.
Axel Grothey, MD, talks about...
04/16/2020
Oncology
No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer
Podcasts
No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer
02/24/2020
Joel Randolph Hecht, MD, discusses findings from the SEQUOIA clinical trial of GEM-refractory pancreatic cancer.
Joel Randolph Hecht, MD, discusses findings from the SEQUOIA clinical trial of GEM-refractory pancreatic cancer.
Joel Randolph Hecht, MD,...
02/24/2020
Oncology
Primary Tumor Resection Plus Chemo Yields No Benefit Over Chemo Alone for Stage IV CRC
Interview
Primary Tumor Resection Plus Chemo Yields No Benefit Over Chemo Alone for Stage IV CRC
02/13/2020
Yukihide Kanemitsu, MD, discusses clinical significance of the JCOG1007 study, the results of which were presented at the 2020 ASCO GI Cancers Symposium.
Yukihide Kanemitsu, MD, discusses clinical significance of the JCOG1007 study, the results of which were presented at the 2020 ASCO GI Cancers Symposium.
Yukihide Kanemitsu, MD,...
02/13/2020
Oncology
CXB After EBRT/EBCRT in Patients With Rectal Cancer Not Eligible for Surgery
Interview
CXB After EBRT/EBCRT in Patients With Rectal Cancer Not Eligible for Surgery
01/28/2020
Arthur Sun Myint, FRCP, FFRCS, FRCR, FICS, discusses the significance of a trial on the role of CXB after EBRT or EBCRT in certain patients with rectal cancer.
Arthur Sun Myint, FRCP, FFRCS, FRCR, FICS, discusses the significance of a trial on the role of CXB after EBRT or EBCRT in certain patients with rectal cancer.
Arthur Sun Myint, FRCP, FFRCS,...
01/28/2020
Oncology
Proton Therapy Improves Survival Over Photon Therapy in HCC
Interview
Proton Therapy Improves Survival Over Photon Therapy in HCC
01/07/2020
Nina Niu Sanford, MD, and Theodore Hong, MD, discuss a study comparing proton- versus photon-based radiation therapy for unresectable HCC.
Nina Niu Sanford, MD, and Theodore Hong, MD, discuss a study comparing proton- versus photon-based radiation therapy for unresectable HCC.
Nina Niu Sanford, MD, and...
01/07/2020
Oncology
Researchers Identify Predictors of RILD in Patients With HCC
Interview
Researchers Identify Predictors of RILD in Patients With HCC
01/06/2020
Cheng-En Hsieh, MD, discusses a study identifying predictors of radiation-induced liver disease (RILD) in patients with HCC treated with proton beam therapy.
Cheng-En Hsieh, MD, discusses a study identifying predictors of radiation-induced liver disease (RILD) in patients with HCC treated with proton beam therapy.
Cheng-En Hsieh, MD, discusses a...
01/06/2020
Oncology
Videos
Eric Van Cutsem, MD, PhD, on the Evolving Treatment Landscape of Pancreatic Cancer
12/05/2019
Dr Van Cutsem talks about how the treatment landscape for pancreatic cancer has evolved in recent years.
Dr Van Cutsem talks about how the treatment landscape for pancreatic cancer has evolved in recent years.
Dr Van Cutsem talks about how...
12/05/2019
Oncology

Advertisement

Advertisement

Advertisement

Section Editor

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center, New York

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement